Catalyzing innovation in cancer drug discovery through artificial intelligence, machine learning and patency

Click to increase image sizeClick to decrease image size

Author contributions

M Okereke conceptualized the idea for this paper. M Okereke, SA Oni, Z Ashimiyu-Abdusalam, OA John-Joy, C Diovu, AA Abdulwahab, AI Jesutimilehin, NEB, IJ Somtochukwuf, OJ Oluwamayowa, KO Olaitan and D-B Samuel wrote the first drafts of this paper. M Okereke wrote the final draft, and reviewed the paper for intellectual content, accuracy and comprehension. All authors agreed and approved the final manuscript.

Financial disclosure

The authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.